Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124535072 | 12453507 | 2 | F | 2013 | 20150918 | 20160609 | 20160720 | EXP | US-DSJP-DSU-2015-118411 | DAIICHI | 0.00 | M | Y | 77.98000 | KG | 20160718 | PH | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124535072 | 12453507 | 1 | PS | BENICAR HCT | HYDROCHLOROTHIAZIDEOLMESARTAN MEDOXOMIL | 1 | UNK | N | 21532 | FILM-COATED TABLET | |||||||||
| 124535072 | 12453507 | 2 | SS | BENICAR | OLMESARTAN MEDOXOMIL | 1 | 20 MG, QD | N | 0 | 20 | MG | TABLET | QD | ||||||
| 124535072 | 12453507 | 3 | SS | BENICAR | OLMESARTAN MEDOXOMIL | 1 | 40 MG, QD | N | 0 | 40 | MG | TABLET | QD | ||||||
| 124535072 | 12453507 | 4 | C | ACIPHEX | RABEPRAZOLE SODIUM | 1 | 20 MG, QD | 0 | 20 | MG | QD | ||||||||
| 124535072 | 12453507 | 5 | C | LOSARTAN POTASSIUM. | LOSARTAN POTASSIUM | 1 | 150 MG, QD | 0 | 150 | MG | QD | ||||||||
| 124535072 | 12453507 | 6 | C | ZANTAC | RANITIDINE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 124535072 | 12453507 | 7 | C | PROTONIX | PANTOPRAZOLE SODIUM | 1 | UNK | 0 | |||||||||||
| 124535072 | 12453507 | 8 | C | AMLODIPINE BESYLATE. | AMLODIPINE BESYLATE | 1 | 5 MG, QD | 0 | 5 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124535072 | 12453507 | 1 | Product used for unknown indication |
| 124535072 | 12453507 | 2 | Hypertension |
| 124535072 | 12453507 | 4 | Product used for unknown indication |
| 124535072 | 12453507 | 5 | Product used for unknown indication |
| 124535072 | 12453507 | 6 | Product used for unknown indication |
| 124535072 | 12453507 | 7 | Product used for unknown indication |
| 124535072 | 12453507 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124535072 | 12453507 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124535072 | 12453507 | Anxiety | |
| 124535072 | 12453507 | Constipation | |
| 124535072 | 12453507 | Diverticulitis | |
| 124535072 | 12453507 | Dizziness | |
| 124535072 | 12453507 | Gastrointestinal disorder | |
| 124535072 | 12453507 | Gastrooesophageal reflux disease | |
| 124535072 | 12453507 | Impaired gastric emptying | |
| 124535072 | 12453507 | Irritable bowel syndrome | |
| 124535072 | 12453507 | Malabsorption |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124535072 | 12453507 | 1 | 2012 | 201503 | 0 | |
| 124535072 | 12453507 | 2 | 201210 | 201503 | 0 | |
| 124535072 | 12453507 | 3 | 201210 | 201503 | 0 | |
| 124535072 | 12453507 | 4 | 2014 | 0 | ||
| 124535072 | 12453507 | 5 | 201410 | 201503 | 0 | |
| 124535072 | 12453507 | 6 | 201410 | 201501 | 0 | |
| 124535072 | 12453507 | 7 | 2012 | 2014 | 0 | |
| 124535072 | 12453507 | 8 | 201412 | 201502 | 0 |